3 Houston innovators to know this week

Who's who

From fitness tech and interior design to super thin wearable technology, this week's innovators to know can't be stopped. Courtesy photos

Another week, another set of Houston innovators to keep your eye on. This week's cast of characters are from across industries — from fitness innovation to interior design for tech companies. Scroll through to meet the people behind Houston innovation.

Lizzie DeLacy, founder of DeLacy Wellness

Photo courtesy of DeLacy Wellness

After years of working in fitness, Lizzie DeLacy, founder of DeLacy Wellness, wanted to be able to help more people on their health and wellness journeys. She launched Bodypeace — an app that offers workout sessions, recipes, and tips for a healthier lifestyle — to help people make time for fitness and mindfulness.

"Rather than focusing on really long sessions, though we have a couple in there, we focus on short 5-minute sessions, so anyone can fit movement into their schedule and lifestyle," DeLacy tells InnovationMap. "Additionally, we break it down by body part focus, because oftentimes people don't know necessarily what exact movement or pose or stretch they might need."

Cunjiang Yu, a Bill D. Cook associate professor of Mechanical Engineering at the University of Houston

Photo courtesy of UH

Cunjiang Yu, a professor and researcher at the University of Houston, is the lead author on a paper that ran as the cover story in Science Advances. In the paper, Yu identifies a wearable technology that can detect health conditions while being so incredibly thin, the wearer might not even notice.

"Everything is very thin, just a few microns thick," says Yu, who also is a principal investigator at the Texas Center for Superconductivity at UH, in a release. "You will not be able to feel it."

Amy English, director of interiors for HOK

Photo courtesy of HOK

For most people, the design of an office might be non-consequential. But, for Amy English, director if interiors for HOK, designing the right space can do wonders for your company. English wrote a guest article for InnovationMap that outlines different trends in interior design for tech companies.

"While the next big technological advancement isn't set in stone, one thing is certain: Companies that wish to remain competitive and responsive in the future will need workplaces with the flexibility and personalization that allow their people to gather, connect, innovate, and simply be their best," she writes.

Read English's guest article here.

Lizzie DeLacy, founder of DeLacy Wellness, launched a new platform called Bodypeace offering wellness and exercise tips through the app. Courtesy of DeLacy Wellness

Houston fitness guru takes her expertise mobile with new app

Fit tech

As time spent on mobile devices stretches longer and attention spans get shorter, a Houstonian thinks she has a solution to combine personal technology and a healthy lifestyle.

Lizzie DeLacy, founder of DeLacy Wellness, has launched a new app called Bodypeace that offers workout sessions, recipes, and tips for a healthier lifestyle, but in a different way than consumers might be used to.

"Rather than focusing on really long sessions, though we have a couple in there, we focus on short 5 minute sessions, so anyone can fit movement into their schedule and lifestyle," DeLacy tells InnovationMap. "Additionally, we break it down by body part focus, because oftentimes people don't know necessarily what exact movement or pose or stretch they might need."

DeLacy worked as a private fitness instructor for years before deciding to create the Bodypeace app to make her coaching and practices accessible to more people. Her goal is to help as many people as possible feel better so they can grow to be the best version of themselves, referring to this concept as "Eventual Energy."

The Bodypeace app, which launched on iTunes and Google Play on July 17, allows users to filter by body part, choosing between an all body session, or focus on a specific spot such as hamstrings, hips, back, shoulders, and more.

"In my experience as a yoga instructor, I saw that these are pain points for a lot of people," says DeLacy.

The app tailors content for the user by asking a series of questions about workout habits, and lifestyle. There is a free trial period for users to explore the app, as well as paid options, $17.99 a month or $119.99 a year.

"The busier people get the less they want to spend time in their cars or pay the fees that are associated with gym memberships, and having the ability to do something from the comfort of your own home or on demand that fits your schedule," says DeLacy. "I think it's really appealing to a lot of people, myself included."

DeLacy shares that many fitness apps out there geared towards getting a six pack or losing weight can be intimidating to those that have never worked out before or have an injury that they're recovering from. She designed her app to be accessible for all fitness levels, ages, and genders.

"The content on Bodypeace is really for the athletes and the 'never-evers' alike," DeLacy tells InnovationMap. "There is a whole group of people that are either new to working out or have never considered it before."

DeLacy founded DeLacy Wellness in 2016, a year after she moved to Houston. DeLacy is a certified yoga instructor and holds a health coaching certification. The company, which is privately funded, has two full-time staff, DeLacy and her partner and COO Jack Martin, two advisory board members, two instructors, and one community contributor.

DeLacy tells InnovationMap that on the community portion of the Bodypeace app, there is a lot of free information available for users to test the content. DeLacy and her team hope to connect wellness content creators and contributors with people who are looking for information to feel and live better.

"We're hoping to create a platform where you're doing movement and you're also going to learn about movement, nutrition, mental health, and other topics dealing with wellness," says DeLacy.

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston space company lands latest NASA deal to advance lunar logistics

To The Moon

Houston-based space exploration, infrastructure, and services company Intuitive Machines has secured about $2.5 million from NASA to study challenges related to carrying cargo on the company’s lunar lander and hauling cargo on the moon. The lander will be used for NASA’s Artemis missions to the moon and eventually to Mars.

“Intuitive Machines has been methodically working on executing lunar delivery, data transmission, and infrastructure service missions, making us uniquely positioned to provide strategies and concepts that may shape lunar logistics and mobility solutions for the Artemis generation,” Intuitive Machines CEO Steve Altemus says in a news release.

“We look forward to bringing our proven expertise together to deliver innovative solutions that establish capabilities on the [moon] and place deeper exploration within reach.”

Intuitive Machines will soon launch its lunar lander on a SpaceX Falcon 9 rocket to deliver NASA technology and science projects, along with commercial payloads, to the moon’s Mons Mouton plateau. Lift-off will happen at NASA’s Kennedy Space Center in Florida within a launch window that starts in late February. It’ll be the lander’s second trip to the moon.

In September, Intuitive Machines landed a deal with NASA that could be worth more than $4.8 billion.

Under the contract, Intuitive Machines will supply communication and navigation services for missions in the “near space” region, which extends from the earth’s surface to beyond the moon.

The five-year deal includes an option to add five years to the contract. The initial round of NASA funding runs through September 2029.

Play it back: Houston home tech startup begins 2025 with fresh funding

HOUSTON INNOVATORS PODCAST EPISODE 272

One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

"It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

"We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME